ATE486876T1 - N-sulfamoyl-n benzopyranpiperidine als hemmer von kohlenstoffanhydrasen - Google Patents

N-sulfamoyl-n benzopyranpiperidine als hemmer von kohlenstoffanhydrasen

Info

Publication number
ATE486876T1
ATE486876T1 AT06829983T AT06829983T ATE486876T1 AT E486876 T1 ATE486876 T1 AT E486876T1 AT 06829983 T AT06829983 T AT 06829983T AT 06829983 T AT06829983 T AT 06829983T AT E486876 T1 ATE486876 T1 AT E486876T1
Authority
AT
Austria
Prior art keywords
sulfamoyl
benzopyranpiperidine
inhibitor
carbon anhydrase
anhydrase
Prior art date
Application number
AT06829983T
Other languages
English (en)
Inventor
Jochen Antel
Harald Waldeck
Uwe Schoen
Peter-Colin Gregory
Michael Wurl
Michael Firnges
Dania Reiche
Uwe Reinecker
Holger Sann
Original Assignee
Abbott Products Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products Gmbh filed Critical Abbott Products Gmbh
Application granted granted Critical
Publication of ATE486876T1 publication Critical patent/ATE486876T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06829983T 2005-11-14 2006-11-14 N-sulfamoyl-n benzopyranpiperidine als hemmer von kohlenstoffanhydrasen ATE486876T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05110724 2005-11-14
PCT/EP2006/068416 WO2007054580A1 (en) 2005-11-14 2006-11-14 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases

Publications (1)

Publication Number Publication Date
ATE486876T1 true ATE486876T1 (de) 2010-11-15

Family

ID=35788569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06829983T ATE486876T1 (de) 2005-11-14 2006-11-14 N-sulfamoyl-n benzopyranpiperidine als hemmer von kohlenstoffanhydrasen

Country Status (17)

Country Link
EP (1) EP1951725B1 (de)
JP (1) JP2009515928A (de)
KR (1) KR20080068099A (de)
CN (1) CN101309923A (de)
AT (1) ATE486876T1 (de)
AU (1) AU2006313725A1 (de)
BR (1) BRPI0618539A2 (de)
CA (1) CA2629864A1 (de)
DE (1) DE602006018053D1 (de)
ES (1) ES2356841T3 (de)
NO (1) NO20082656L (de)
PL (1) PL1951725T3 (de)
PT (1) PT1951725E (de)
RU (1) RU2008123395A (de)
UA (1) UA94596C2 (de)
WO (1) WO2007054580A1 (de)
ZA (1) ZA200803809B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008209320B2 (en) * 2007-01-25 2013-05-30 NAIA Metabolic, Inc. Insulin sensitisers and methods of treatment
WO2018112204A1 (en) * 2016-12-14 2018-06-21 Cephalon, Inc. Spiropiperidine derivatives
CN110872302B (zh) * 2018-08-31 2022-09-27 沈阳中化农药化工研发有限公司 含嘧啶的螺环类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691296B2 (en) * 1994-05-06 1998-05-14 Pharmacopeia Drug Discovery, Inc. Combinatorial dihydrobenzopyran library
JPWO2004092179A1 (ja) * 2003-04-14 2006-07-06 日本曹達株式会社 スピロ誘導体、製造法および抗酸化薬
JP2005119987A (ja) * 2003-10-15 2005-05-12 Ajinomoto Co Inc アシルスルホンアミド誘導体

Also Published As

Publication number Publication date
RU2008123395A (ru) 2009-12-27
UA94596C2 (ru) 2011-05-25
AU2006313725A1 (en) 2007-05-18
NO20082656L (no) 2008-08-13
PL1951725T3 (pl) 2011-04-29
BRPI0618539A2 (pt) 2011-09-06
DE602006018053D1 (de) 2010-12-16
JP2009515928A (ja) 2009-04-16
CA2629864A1 (en) 2007-05-18
ZA200803809B (en) 2009-10-28
WO2007054580A1 (en) 2007-05-18
EP1951725B1 (de) 2010-11-03
CN101309923A (zh) 2008-11-19
PT1951725E (pt) 2011-01-14
EP1951725A1 (de) 2008-08-06
ES2356841T3 (es) 2011-04-13
KR20080068099A (ko) 2008-07-22

Similar Documents

Publication Publication Date Title
SE0403006D0 (sv) New compounds
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA200702339A1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
UA84048C2 (ru) Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
CO6150162A2 (es) Pirrolopirimidinas para composiciones farmaceuticas
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
PT1960352E (pt) Derivados de 2-adamantilureia como inibidores seletivos de 11â-hsd1
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
WO2006093547A3 (en) Novel lipoxygenase inhibitors
EA200601462A1 (ru) Соединения для лечения заболеваний
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BR112014006763A2 (pt) n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
EP2091328A4 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
EP1817312A4 (de) Makrozyklische aminiopyridyl-beta-sekretase-hemmer zur behandlung von morbus alzheimer
EA201071039A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
EP2257161A4 (de) Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
MX2023009222A (es) Inhibidores tricíclicos-amido-bicíclicos de prmt5.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1951725

Country of ref document: EP